# FRP Holdings, Inc.: financial statements, quarterly

FRPH · Nasdaq · CIK 844059 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/frph.md) · [Financials](/companies/frph/financials.md) · [Filings](/companies/frph/filings.md) · [Insiders](/companies/frph/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/frph/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.6](/filings/0000844059-24-000041.md) | [10.1 d](/filings/0000844059-26-000037.md) | [10.1](/filings/0000844059-25-000019.md) | [10.5](/filings/0000844059-25-000050.md) | [10.6](/filings/0000844059-25-000064.md) | [10.5 d](/filings/0000844059-26-000037.md) | [10.3](/filings/0000844059-26-000069.md) | [10.9](/filings/0000844059-26-000086.md) | [10.8](/filings/0000844059-25-000064.md) | [10.9 d](/filings/0000844059-26-000037.md) | [10.6](/filings/0000844059-26-000069.md) | [11.1](/filings/0000844059-26-000086.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [2.9](/filings/0000844059-24-000041.md) | [3.2 d](/filings/0000844059-26-000037.md) | [2.9](/filings/0000844059-25-000019.md) | [2.8](/filings/0000844059-25-000050.md) | [3.1](/filings/0000844059-25-000064.md) | [2.9 d](/filings/0000844059-26-000037.md) | [2.3](/filings/0000844059-26-000069.md) | [1.7](/filings/0000844059-26-000086.md) | [1.4](/filings/0000844059-25-000064.md) | [1.7 d](/filings/0000844059-26-000037.md) | [0.5](/filings/0000844059-26-000069.md) | [1.5](/filings/0000844059-26-000086.md) |
| Interest expense | $m | [1.1](/filings/0000844059-23-000038.md) | [1.1 d](/filings/0000844059-24-000018.md) | [0.9](/filings/0000844059-24-000032.md) | [0.8](/filings/0000844059-25-000050.md) | [0.7](/filings/0000844059-25-000064.md) | [0.7 d](/filings/0000844059-26-000037.md) | [0.7](/filings/0000844059-26-000069.md) | [0.8](/filings/0000844059-26-000086.md) | [0.7](/filings/0000844059-25-000064.md) | [0.7 d](/filings/0000844059-26-000037.md) | [0.7](/filings/0000844059-26-000069.md) | [0.7](/filings/0000844059-26-000086.md) |
| Income tax | $m | [0.5](/filings/0000844059-24-000041.md) | [0.6 d](/filings/0000844059-26-000037.md) | [0.4](/filings/0000844059-25-000019.md) | [0.9](/filings/0000844059-25-000050.md) | [0.4](/filings/0000844059-25-000064.md) | [0.3 d](/filings/0000844059-26-000037.md) | [0.5](/filings/0000844059-26-000069.md) | [0.2](/filings/0000844059-26-000086.md) | [0.2](/filings/0000844059-25-000064.md) | [(0.1) d](/filings/0000844059-26-000037.md) | [(0.2)](/filings/0000844059-26-000069.md) | [(0.1)](/filings/0000844059-26-000086.md) |
| Net income | $m | [1.3](/filings/0000844059-24-000041.md) | [2.9 d](/filings/0000844059-26-000037.md) | [1.3](/filings/0000844059-25-000019.md) | [2.0](/filings/0000844059-25-000050.md) | [1.4](/filings/0000844059-25-000064.md) | [1.7 d](/filings/0000844059-26-000037.md) | [1.7](/filings/0000844059-26-000069.md) | [0.6](/filings/0000844059-26-000086.md) | [0.7](/filings/0000844059-25-000064.md) | [0.4 d](/filings/0000844059-26-000037.md) | [(0.7)](/filings/0000844059-26-000069.md) | [(0.3)](/filings/0000844059-26-000086.md) |
| Diluted EPS | $ per share | [0.07](/filings/0000844059-24-000041.md) | not reported | [0.07](/filings/0000844059-25-000019.md) | [0.11](/filings/0000844059-25-000050.md) | [0.07](/filings/0000844059-25-000064.md) | not reported | [0.09](/filings/0000844059-26-000069.md) | [0.03](/filings/0000844059-26-000086.md) | [0.03](/filings/0000844059-25-000064.md) | not reported | [(0.04)](/filings/0000844059-26-000069.md) | [(0.01)](/filings/0000844059-26-000086.md) |
| Basic EPS | $ per share | [0.07](/filings/0000844059-24-000041.md) | not reported | [0.07](/filings/0000844059-25-000019.md) | [0.11](/filings/0000844059-25-000050.md) | [0.07](/filings/0000844059-25-000064.md) | not reported | [0.09](/filings/0000844059-26-000069.md) | [0.03](/filings/0000844059-26-000086.md) | [0.03](/filings/0000844059-25-000064.md) | not reported | [(0.04)](/filings/0000844059-26-000069.md) | [(0.01)](/filings/0000844059-26-000086.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [166](/filings/0000844059-23-000038.md) | [158](/filings/0000844059-25-000009.md) | [152](/filings/0000844059-24-000032.md) | [157](/filings/0000844059-24-000039.md) | [145](/filings/0000844059-24-000041.md) | [149](/filings/0000844059-25-000064.md) | [143](/filings/0000844059-25-000019.md) | [153](/filings/0000844059-25-000050.md) | [135](/filings/0000844059-25-000064.md) | not reported | not reported | not reported |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [701](/filings/0000844059-23-000038.md) | [709](/filings/0000844059-26-000037.md) | [706](/filings/0000844059-24-000032.md) | [712](/filings/0000844059-24-000039.md) | [727](/filings/0000844059-24-000041.md) | [728](/filings/0000844059-26-000037.md) | [717](/filings/0000844059-25-000019.md) | [723](/filings/0000844059-25-000050.md) | [731](/filings/0000844059-25-000064.md) | [735](/filings/0000844059-26-000086.md) | [750](/filings/0000844059-26-000069.md) | [762](/filings/0000844059-26-000086.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [256](/filings/0000844059-23-000038.md) | [261](/filings/0000844059-25-000009.md) | [257](/filings/0000844059-24-000032.md) | [261](/filings/0000844059-24-000039.md) | [260](/filings/0000844059-24-000041.md) | [259](/filings/0000844059-26-000037.md) | [257](/filings/0000844059-25-000019.md) | [261](/filings/0000844059-25-000050.md) | [269](/filings/0000844059-25-000064.md) | [279](/filings/0000844059-26-000086.md) | [296](/filings/0000844059-26-000069.md) | [307](/filings/0000844059-26-000086.md) |
| Long-term debt | $m | [179](/filings/0000844059-23-000038.md) | [179](/filings/0000844059-25-000009.md) | [179](/filings/0000844059-24-000032.md) | [179](/filings/0000844059-24-000039.md) | [179](/filings/0000844059-24-000041.md) | [179](/filings/0000844059-26-000037.md) | [178](/filings/0000844059-25-000019.md) | [180](/filings/0000844059-25-000050.md) | [185](/filings/0000844059-25-000064.md) | [193](/filings/0000844059-26-000086.md) | [204](/filings/0000844059-26-000069.md) | [215](/filings/0000844059-26-000086.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [411](/filings/0000844059-23-000038.md) | [415](/filings/0000844059-25-000009.md) | [416](/filings/0000844059-24-000032.md) | [419](/filings/0000844059-24-000039.md) | [421](/filings/0000844059-24-000041.md) | [423](/filings/0000844059-26-000037.md) | [425](/filings/0000844059-25-000019.md) | [427](/filings/0000844059-25-000050.md) | [428](/filings/0000844059-25-000064.md) | [429](/filings/0000844059-26-000086.md) | [428](/filings/0000844059-26-000069.md) | [429](/filings/0000844059-26-000086.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.9 d](/filings/0000844059-24-000041.md) | [12.3 d](/filings/0000844059-26-000037.md) | [2.9](/filings/0000844059-25-000019.md) | [12.2 d](/filings/0000844059-25-000050.md) | [6.3 d](/filings/0000844059-25-000064.md) | [7.6 d](/filings/0000844059-26-000037.md) | [4.5](/filings/0000844059-26-000069.md) | [7.7 d](/filings/0000844059-26-000086.md) | [9.0 d](/filings/0000844059-25-000064.md) | [8.4 d](/filings/0000844059-26-000037.md) | [9.7](/filings/0000844059-26-000069.md) | [1.1 d](/filings/0000844059-26-000086.md) |
| Capital expenditure | $m | [2.4](/filings/0000844059-23-000038.md) | [6.6 d](/filings/0000844059-26-000037.md) | [6.2](/filings/0000844059-25-000019.md) | [6.3 d](/filings/0000844059-25-000050.md) | [34.6 d](/filings/0000844059-25-000064.md) | [4.1 d](/filings/0000844059-26-000037.md) | [3.1](/filings/0000844059-26-000069.md) | [5.1 d](/filings/0000844059-26-000086.md) | [26.0 d](/filings/0000844059-25-000064.md) | [17.0 d](/filings/0000844059-26-000037.md) | [13.4](/filings/0000844059-26-000069.md) | [13.1 d](/filings/0000844059-26-000086.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [1.0 d](/filings/0000844059-24-000041.md) | [0.0 d](/filings/0000844059-26-000037.md) | not reported | not reported | [0.0 d](/filings/0000844059-24-000041.md) | [0.0 d](/filings/0000844059-26-000037.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.4](/filings/0000844059-23-000038.md) | [18.9](/filings/0000844059-24-000032.md) | [18.9](/filings/0000844059-24-000039.md) | [18.9](/filings/0000844059-24-000041.md) | [18.9](/filings/0000844059-25-000019.md) | [18.9](/filings/0000844059-25-000050.md) | [19.0](/filings/0000844059-25-000064.md) | [19.0](/filings/0000844059-26-000069.md) | [19.0](/filings/0000844059-26-000086.md) | [19.0](/filings/0000844059-25-000064.md) | [19.0](/filings/0000844059-26-000069.md) | [19.1](/filings/0000844059-26-000086.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,198,301 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0000844059-26-000086.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.